Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success

Go back to Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 219.07 --0 (-0%)
Previous Close $219.07    52 Week High $333.65 
Open $219.07    52 Week Low $223.02 
Day High $219.07    P/E 28.05 
Day Low $219.07    EPS $7.81 
Volume 378